Search the Newsreel

Lovesac Co (LOVE) Financial Health: Profitability & Balance Sheet Analysis

Lovesac Co (LOVE) holds a financial score of 7.35, placing it 10th out of 23 companies in the Household Goods industry, indicating stable financial health and average operating efficiency. The company's latest quarterly revenue was $138.20 million, a 0.13% year-over-year decrease, with net profit …

Plover Bay Technologies Declares Interim Dividend for First Half of 2026

Plover Bay Technologies Limited 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:PBTDF) 2026-07-30

Plover Bay Technologies: Strong revenue and profit growth driven by recurring sales and high-end products, with robust margins

LOVE|Lovesac Co|Price:16.570|Chg%:-0.400

This article provides a detailed financial overview of Lovesac Co (LOVE), including its market data, financial summaries, income statements, balance sheets, and cash flow statements. It highlights the company's latest earnings report with an EPS of -0.76 and revenue of $138.20M, alongside a "BUY" …

Clover Health Investments (CLOV) to Announce Earnings on Wednesday

Lovesac Co (LOVE) Institutional Confidence

Lovesac Co (LOVE) has an institutional shareholding score of 10.00, placing it first in the Household Goods industry. The latest institutional shareholding proportion is 112.63%, a 21.03% increase quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 0.05% of outstanding shares despite …

The Lovesac Company Revenue Breakdown – NASDAQ:LOVE

The Lovesac Company (NASDAQ: LOVE) generated total revenue of $697.12 million USD last year. Its top-performing segment, Sactionals, contributed $634.79 million USD, an increase from $621.90 million USD in the prior year. The United States was the primary revenue source, accounting for the entire …

Clover Health Investments, Corp. Revenue Breakdown – NASDAQ:CLOV

Firing on All Cylinders: Lovesac (NASDAQ:LOVE) Q1 Earnings Lead the Way

Lovesac (NASDAQ:LOVE) delivered a strong Q1, exceeding analyst revenue expectations and providing upbeat guidance, despite overall industry headwinds impacting the consumer discretionary home furnishings sector. While its peers struggled with missed estimates and declining stock prices, Lovesac showed resilience through strategic product innovation and …

Clover Health Investments Corp. Class A Revenue Breakdown – MUN:7QD

Clover Health Investments Corp. (MUN:7QD) generated €1.64 billion in revenue last year, primarily from its Insurance segment. All of this revenue, €1.64 billion, originated from the United States, indicating the company's strong focus on the US market in the life and health insurance sector.

LOVE|Lovesac Co|Price:16.340|Chg%:-0.030

The article provides an overview of Lovesac Co (LOVE), highlighting its healthy fundamentals, high growth potential, and fair valuation within the Household Goods industry. It notes strong institutional ownership and recent analyst "Buy" ratings with a target price indicating significant upside. Despite average short-term …

Clover Health Data Breach Lawsuit Investigation

Shamis & Gentile P.A. is investigating a data breach involving Clover Health Investments, Corp. dba Clover Health. The breach, which was detected on July 8, 2020, and disclosed to the SEC on July 4, 2026, exposed sensitive personally identifiable and protected health information. Individuals …

I Love Lund ökar substansvärdet

Lovesac stock holds on revenue growth and margin pressure

Lovesac reported fiscal 2025 revenue of $700.3 million, a 4.7% increase from the previous year, but net income decreased from $16.3 million to $10.8 million, largely due to a lower gross margin of 6.7% compared to 8.0%. The company's latest quarterly revenue was $137.5 …

Clover Health CEO Jamie Reynoso sells $21,920 in CLOV stock By Investing.com

Clover Health's Medicare Advantage CEO, Jamie L. Reynoso, sold 4,839 shares of CLOV stock for $21,920, at a weighted average price of $4.53 per share, according to a Rule 10b5-1 trading plan. This transaction occurred after Clover Health shares surged 73% in six months, …

The Lovesac Company (NASDAQ:LOVE) Receives Consensus Rating of "Moderate Buy" from Brokerages

The Lovesac Company (NASDAQ:LOVE) has received a consensus "Moderate Buy" rating from brokerages, with an average 1-year price target of $22.67. Recent analyst actions have been mixed but generally positive, including target increases and upgrades. Insider buying activity, particularly by Director Andrew R. Heyer, …

Lovesac director Vineet Mehra sells 5,000 shares worth $91,909

Lovesac director Vineet Mehra sold 5,000 common shares on July 17, 2026, for $18.38 each, totaling $91,909. This transaction reduced his direct stake to 17,992 shares. The information was generated by AI based on an SEC filing by Lovesac Company.

Clover Health CEO, Medicare Advantage Jamie L. Reynoso disposes of 4,839 shares for $21,920.67

Jamie L. Reynoso, CEO of Clover Health Medicare Advantage, sold 4,839 Class A common shares on July 17, 2026, for a total of $21,920.67 at a price of $4.53 per share. Following this transaction, Reynoso's direct stake in Clover Health fell to 2.81 million …

Clover Health Investments (CLOV) insider sells 4,839 shares under 10b5-1

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (CLOV), sold 4,839 shares of Class A Common Stock on July 17, 2026. The shares were sold at a weighted average price of $4.53 per share, ranging from $4.35 to $4.63, as …

Lovesac Co (LOVE) director Vineet Mehra sells 5,000 common shares

Lovesac Co director Vineet Mehra sold 5,000 shares of common stock on July 17, 2026, at an average price of $18.3817 per share. Following this transaction, Mehra directly holds 17,992 shares of Lovesac common stock. The sale, valued at approximately $92,000, was not conducted …

Clover Health (CLOV) interim CFO sells 4,630 shares to cover taxes

Clover Health's interim CFO, Joseph Clay, sold 4,630 shares of Class A Common Stock on July 15, 2026, at a weighted average price of $4.67 per share. This sale was a mandatory "sell-to-cover" transaction to satisfy tax withholding obligations related to the vesting of …

Clover Health CEO Andrew Toy sells $292,860 in shares

Clover Health CEO Andrew Toy sold 62,711 shares of Class A Common Stock for approximately $292,860 on July 15, 2026. This sale was non-discretionary, made to cover tax withholding obligations associated with the vesting of restricted stock units. Despite the sale, Toy still directly …

Form 144 Lovesac Co For: 16 July By Investing.com

This article is a Form 144 filing for Lovesac Co, dated July 16. It is published by Investing.com, which also includes disclaimers about the high risks involved in trading financial instruments and cryptocurrencies. The content emphasizes that data provided is not necessarily real-time or …

LOVE (Nasdaq: LOVE) holder plans sale of 15,000 shares in Form 144

A shareholder of Lovesac Co. (LOVE) has filed a Form 144 indicating an intent to sell up to 15,000 shares of common stock, valued at $249,150.00, through Morgan Stanley Smith Barney LLC on Nasdaq on July 16, 2026. The filing also details recent employee …

Clover Health: Counterpart Health CEO Wai sells $113,084 in stock.

Conrad Wai, CEO of Counterpart Health at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 24,215 shares of the company’s Class A Common Stock for $113,084. This sale was a "sell to cover" transaction to fulfill tax withholding obligations tied to the vesting of restricted stock …

Clover Health (CLOV) CEO sells 62,711 shares for RSU tax withholding

Clover Health Investments CEO Andrew Toy sold 62,711 Class A shares at a weighted average price of $4.67 per share. This mandatory "sell to cover" transaction was executed to fulfill tax withholding obligations tied to the vesting of 6.25% of his restricted stock units …

Clover Health Investments (CLOV) legal chief sells shares in tax-cover transaction

Clover Health Investments' Chief Legal Officer, Karen Soares, sold 10,519 shares of Class A common stock at a weighted average price of $4.67 per share on July 15, 2026. This transaction was to cover tax withholding obligations from the vesting of restricted stock units …

Clover Health (NASDAQ: CLOV) insider sale covers RSU tax obligations

Clover Health insider Wai Conrad sold 24,215 Class A shares on July 15, 2026, at a weighted average price of $4.67 per share. This sale was a non-discretionary "sell to cover" transaction to satisfy tax withholding obligations from the vesting of 6.25% of his …

Sale of 12,712 shares planned in CLOV (Nasdaq: CLOV) notice

An affiliate of Clover Health Investments (Nasdaq: CLOV) plans to sell 12,712 Class A common shares, valued at $59,492.16, through Morgan Stanley Smith Barney LLC around July 15, 2026. These shares originated from restricted stock units granted as compensation. The filing also notes previous …

CLOV (Nasdaq: CLOV) plans Rule 144 sale of 60765 shares

Clover Health Investments, Corp. (Nasdaq: CLOV) has filed a Form 144 notice for the planned sale of 60,765 shares of Class A Common Stock. These shares originate from Restricted Stock Units granted as compensation and are scheduled to be sold on Nasdaq via Morgan …

CLOV (CLOV) plans sale of 23,463 Class A common shares

Clover Health Investments, Corp. (CLOV) has filed a Form 144 disclosing a planned sale of 23,463 shares of Class A Common Stock with an aggregate market value of $109,806.84 through Morgan Stanley Smith Barney LLC on July 15, 2026. These shares originated from restricted …

Market Share Gains Assert The Lovesac Company (LOVE) as a Top High Growth Micro-Cap Stock

Lovesac (LOVE) Stock Faces Q1 Loss As Thin Margins Test Bullish Earnings Narrative

Lovesac Q1 Earnings Call Highlights Product Push, Outlook

LOVESAC (THE ($LOVE) Releases Q1 2027 Earnings